Levetiracetam
![APTIOM (Eslicarbazepine Acetate) Is (S)-10-Acetoxy-10,11-Dihydro-5H Dibenz[B,F]Azepine-5-Carboxamide](http://data.docslib.org/img/264x/17c0ce36a7672716ab0ae81a91d3c133.webp)
Top View
- Chapter 26 Starting Antiepileptic Drug Treatment
- APTIOM (Eslicarbazepine Acetate) Tablets, for Oral Use • Withdrawal of APTIOM: Withdraw APTIOM Gradually to Minimize the Initial U.S
- Study Protocol SEP093-701
- Levetiracetam Induces a Rapid and Sustained Reduction of Generalized Spike-Wave and Clinical Absence
- Prescribing Information
- Seizure Outcome After Switching Antiepileptic Drugs: a Matched, Prospective Study
- Levetiracetam (Keppra®)
- The Safety of Medications Used to Treat
- The New Antiepileptic Drugs Scientific Review
- Keppra, INN-Levetiracetam
- MEDICATION GUIDE Levetiracetam Tablets 250 Mg, 500 Mg and 750
- Risk of Ischaemic Stroke Associated with Antiepileptic Drugs
- Levetiracetam Versus Phenytoin for Second-Line Treatment of Convulsive
- MEDICATION GUIDE Levetiracetam Tablets 250 Mg, 500 Mg, 750 Mg, 1000 Mg Read This Medication Guide Before You Start Taking Levetiractem and Each Time You Get a Refill
- 2-Pyrrolidinone and Succinimide As Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-Seizure Medications Impact Accurate Diagnosis
- Long-Term Observational Study of Eslicarbazepine Acetate Monotherapy
- Efficacy and Safety of Conversion to Monotherapy with Eslicarbazepine
- Antiepileptics – Levetiracetam, Brivaracetam